Can dialysis treat hyperkalemia (elevated potassium levels)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Dialysis is a highly effective treatment for hyperkalemia, particularly in emergency situations or for patients with kidney failure who cannot excrete potassium normally. The process of dialysis removes excess potassium from the blood by filtering it through a semipermeable membrane, allowing potassium to diffuse from areas of high concentration (the patient's blood) to areas of lower concentration (the dialysate solution) 1. Both hemodialysis and peritoneal dialysis can lower potassium levels, though hemodialysis works more rapidly and is preferred for severe or life-threatening hyperkalemia.

According to recent clinical studies, the management of hyperkalemia involves a combination of treatments, including the use of potassium-binding agents, loop diuretics, and in severe cases, dialysis 1. The effectiveness of dialysis for potassium removal depends on treatment duration, blood flow rate, dialysate potassium concentration, and the patient's total body potassium burden. For patients with chronic kidney disease, diabetes, heart failure, or a history of hyperkalemia, individualized monitoring of serum potassium levels is crucial, and the use of newer potassium-binding agents may facilitate optimization of renin-angiotensin-aldosterone system inhibitor (RAASi) therapy 1.

In emergency situations with severe hyperkalemia (>6.5 mEq/L) accompanied by ECG changes or symptoms, urgent hemodialysis may be necessary alongside other temporizing measures such as calcium gluconate, insulin, or sodium bicarbonate. The clinical management of hyperkalemia requires a comprehensive approach, including classification, potassium monitoring, and the appropriate use of oral potassium-binding agents 1.

Key considerations in the management of hyperkalemia include:

  • Individualized monitoring of serum potassium levels
  • Use of potassium-binding agents, such as patiromer sorbitex calcium and sodium zirconium cyclosilicate
  • Optimization of RAASi therapy
  • Dialysis for severe or life-threatening hyperkalemia
  • Temporary measures, such as calcium gluconate, insulin, or sodium bicarbonate, for emergency situations.

Overall, dialysis is a critical component of hyperkalemia management, particularly for patients with kidney failure or severe hyperkalemia, and should be used in conjunction with other treatments to optimize patient outcomes 1.

From the Research

Treatment of Hyperkalemia

Dialysis can be an effective treatment for hyperkalemia, particularly in patients with end-stage renal disease (ESRD) [(2,3)]. The process helps remove excess potassium from the blood, thus lowering serum potassium levels.

Effectiveness of Dialysis

  • Dialysis is considered the definitive treatment for hyperkalemia in patients with ESRD 3.
  • It can help manage hyperkalemia by removing excess potassium from the blood [(2,3)].
  • However, dialysis may not be necessary for all cases of severe hyperkalemia, especially in patients with intact renal function 4.

Alternative Management Options

  • In addition to dialysis, other management options for hyperkalemia include dietary potassium restriction, avoidance of medications that increase hyperkalemia risk, and the use of potassium-binding agents [(2,5)].
  • Potassium-binding agents, such as patiromer and sodium zirconium cyclosilicate, can help reduce serum potassium levels and may allow patients to maintain renin-angiotensin-aldosterone system (RAAS) inhibitor therapy and consume a potassium-rich diet 5.

Considerations for Dialysis Patients

  • Patients receiving hemodialysis are particularly susceptible to hyperkalemia during long interdialytic intervals 5.
  • Managing hyperkalemia in these patients can be challenging, and potassium-binding agents may play a role in preventing hyperkalemia 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.